References
- Schaeffer HJ, Beauchamp L, de Miranda P, et al. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature 1978 Apr, 272: 583–5
- Elion GB, Furman PA, Fyfe JA, et al. Selectivity of action of an antiherpetic agent 9-(2-hydroxyethoxy-methyl) guanine. Proc Natl Acad Sci 1977: 74(12): 5716–20
- Crumpacker CS, Schnipper LE, Zaia JA, et al. Growth Inhibition by acycloguanosine of herpesviruses isolated from human Infections. Antimicrob Agents Chemother 1979: 15(5):642–5
- Field HJ, Larder BA, Darby G. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus. Am J Med 1982: 73(1A):369–71 (Entire Issue devoted to preclinical and early clinical experience with acyclovir)
- Biron KK, Elion GB. In vitro susceptibility of varicella-zoster virus to acyclovir. Antimicrob Agents Chemother 1980: 18(3):443–7
- Colby BM, Shaw JE, Elion GB, et al. Effect of acyclovir [9-(2-hydroxyethoxymethyl) guaninel on Epstein-Barr virus DNA replication. J Virol 1980: 34 (2)560–8
- Tyms AS, Seaman EM, Naim HM. The In vitro activity of acyclovir and related compounds against cytomegalovirus infections. J Antimicrob Chemother 1981: 8(1):65–72
- Nilsen AE, Aasen T, Halsos AM, et al. Efficacy of oral acyclovir In the treatment of Initial and recurrent genital herpes. Lancet 19822(8298):571–3
- Mindel A, Adler MW, Sutherland S, et al. Intravenous acyclovir treatment for primary genital herpes. Lancet 1982: 1(8274)697–700
- Corey L, Nahmias AJ, Gujnan ME, et al. A trial of topical acyclovir in genital herpes simplex virus Infections. N Engl J Med 1982: 306(22):1313–9
- Reichman RC, Badger GS, Richman DO, et al. Treatment of recurrent herpes simplex genitalis with orally administered acyclovir. Presented at 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy.Miami: 1982 Oct 4 (Abstr 183)
- Klein RJ. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds. Am J Med 1982: 73(1A):138–42
- Straus SE, Smith HA. Brickman C, et al. Acyclovir for chronic mucocutaneous herpes simplex virus infection in Immunosuppressed patients. Ann Intern Med 198236(3):270–7
- Spruance SL, Schnipper LE, Overall JC Jr, et al. Treatment of herpes simplex labialis with topical acyclovir In polyethylene glycol. J Infect Dis 1982: 146(1):85–90
- Mitchell CD, Bean B, Gentry SR, et al. Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet 1981: 1 (8235):1389–92
- Wade JC, Newton B, McLaren C, et al. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial Ann Intern Med 198296(3)265–9
- Saral R, Burns WH, Laskin OL, et al. Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med 1981: 305(2):63–7
- Bean B, Braun C, Balfour HH Jr. Acyclovir therapy for acute herpes zoster. Lancet 1982: 2(8290):118–21
- Peterslund NA, Seyer-Hansen K, Ipsen J, et al. Acyclovir In herpes zoster. Lancet 1981: 2(8251):827–30
- Prober CG, Kirk LE, Keeney RE. Acyclovir therapy of chickenpox in Immunosuppressed children: a collaborative study. J Pediatr 1982: 101(4):622–5
- Balfour HH Jr, Bean B, Mitchell CD, et al. Acyclovir in immunocompromised patients with cytomegalovirus disease: a controlled trial at one Institution. Am J Med 1982;73(1A)241–8
- Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 1982: 306(15)313–8
- Blum MR, Liao SH, de Miranda P. Overview of acyclovir pharmacokinetic disposition in adults and children. Am J Med 1982;73(1A):186–92
- Cockroft DN, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976: 16: 31–41
- Whitley RJ, Blum MR, Barton N, et al. Pharmacokinetics of acyclovir In humans following intravenous administration: a model for the development of parenteral antivirals. Am J Med 1982;73(1A):165–71
- Bean B, Braun C, Mitchell CD, et al. Acyclovir for treatment of zoster in Immunocompromised hosts. Presented at 2nd International Symposium on infections in the Immunocompromised Host. Stirling, Scotland: 1982 Jun 23
- Bean B, Balfour HH Jr. Adverse effects of acyclovir in otherwise normal patients with acute zoster. Presented at 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Miami: 1982 Oct 4 (Abstr 185)
- Wade JC, Hintz M, McGuffin RW, et al. Treatment of cytomegalovirus pneumonia with high-dose acyclovir. Am J Med 1982: 731(1A):249–56